What is Ardent Health's earnings per share (EPS)?

Ardent Health (ARDT) reported diluted earnings per share of $0.96 for fiscal year 2025. This represents a -39.2% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Ardent Health Financials

ARDT

Source SEC Filings (10-K/10-Q) Updated Dec 31, 2025 Currency USD FYE December

This page shows Ardent Health (ARDT) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 4 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Financial Health Signals

Financial Profile 50/100

Based on FY2025 annual data. Scores normalized against common benchmarks. How we calculate these scores

Growth

Ardent Health's revenue grew 6.0% year-over-year to $6.3B, a solid pace of expansion. This earns a growth score of 43/100.

Leverage

Ardent Health carries a low D/E ratio of 0.84, meaning only $0.84 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 85/100, indicating a strong balance sheet with room for future borrowing.

Liquidity

Ardent Health's current ratio of 1.97 indicates adequate short-term liquidity, earning a score of 35/100. The company can meet its near-term obligations, though with limited headroom.

Returns

Ardent Health's ROE of 10.5% shows moderate profitability relative to equity, earning a score of 35/100. This is down from 18.6% the prior year.

Piotroski F-Score Neutral

5/9

Ardent Health passes 5 of 9 financial strength tests. 3 of 4 profitability signals pass, 2 of 3 leverage/liquidity signals pass, neither operating efficiency signal passes.

Earnings Quality Cash-Backed

3.46x

For every $1 of reported earnings, Ardent Health generates $3.46 in operating cash flow ($470.5M OCF vs $135.8M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$6.3B

YoY+6.0%

Ardent Health generated $6.3B in revenue in fiscal year 2025. This represents an increase of 6.0% from the prior year.

EBITDA

N/A

Net Income

$135.8M

YoY-35.4%

Ardent Health reported $135.8M in net income in fiscal year 2025. This represents a decrease of 35.4% from the prior year.

EPS (Diluted)

$0.96

YoY-39.2%

Ardent Health earned $0.96 per diluted share (EPS) in fiscal year 2025. This represents a decrease of 39.2% from the prior year.

Cash & Balance Sheet

Free Cash Flow

N/A

Cash & Debt

$709.6M

YoY+27.4%

Ardent Health held $709.6M in cash against $1.1B in long-term debt as of fiscal year 2025.

Dividends Per Share

N/A

Shares Outstanding

143M

YoY+0.1%

Ardent Health had 143M shares outstanding in fiscal year 2025. This represents an increase of 0.1% from the prior year.

Margins & Returns

Gross Margin

N/A

Operating Margin

N/A

Net Margin

2.1%

YoY-1.4pp

Ardent Health's net profit margin was 2.1% in fiscal year 2025, showing the share of revenue converted to profit. This is down 1.4 percentage points from the prior year.

Return on Equity

10.5%

YoY-8.0pp

Ardent Health's ROE was 10.5% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is down 8.0 percentage points from the prior year.

Capital Allocation

R&D Spending

N/A

Share Buybacks

N/A

Capital Expenditures

N/A

ARDT Income Statement

Metric	FY25	FY24	FY23	FY22
Revenue	$6.3B+6.0%	$6.0B+10.3%	$5.4B+5.5%	$5.1B
Cost of Revenue	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A
R&D Expenses	N/A	N/A	N/A	N/A
SG&A Expenses	$140.8M+6.3%	$132.4M+15.5%	$114.6M+52.2%	$75.3M
Operating Income	N/A	N/A	N/A	N/A
Interest Expense	$55.2M-15.8%	$65.6M-11.7%	$74.3M	N/A
Income Tax	$56.2M-11.3%	$63.4M+179.9%	$22.6M-50.9%	$46.1M
Net Income	$135.8M-35.4%	$210.3M+290.2%	$53.9M-71.5%	$188.9M
EPS (Diluted)	$0.96-39.2%	$1.58+267.4%	$0.43-71.3%	$1.50

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Revenue	$1.6B+1.8%	$1.6B-4.2%	$1.6B+9.9%	$1.5B-6.8%	$1.6B+10.8%	$1.4B-1.4%	$1.5B+2.2%	$1.4B
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$36.8M+0.8%	$36.5M+12.0%	$32.6M-6.6%	$34.9M-4.9%	$36.7M+8.9%	$33.7M+15.8%	$29.1M-11.6%	$32.9M
Operating Income	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Interest Expense	$12.4M-11.0%	$13.9M-5.5%	$14.7M+3.9%	$14.2M+4.8%	$13.5M-7.5%	$14.6M-19.4%	$18.2M-5.7%	$19.3M
Income Tax	$18.1M+631.1%	-$3.4M-113.0%	$26.3M+72.6%	$15.2M-42.2%	$26.4M+138.2%	$11.1M-27.3%	$15.2M+42.1%	$10.7M
Net Income	$45.0M+291.5%	-$23.5M-132.2%	$73.0M+76.3%	$41.4M-63.8%	$114.2M+333.9%	$26.3M-38.5%	$42.8M+58.1%	$27.0M
EPS (Diluted)	N/A	$-0.17-132.7%	$0.52+79.3%	$0.29	N/A	$0.19-44.1%	$0.34+61.9%	$0.21

ARDT Balance Sheet

Metric	FY25	FY24	FY23	FY22
Total Assets	$5.3B+6.7%	$5.0B+4.7%	$4.7B	N/A
Current Assets	$2.1B+12.3%	$1.8B+13.3%	$1.6B	N/A
Cash & Equivalents	$709.6M+27.4%	$556.8M+27.2%	$437.6M-4.1%	$456.1M
Inventory	$118.6M+3.0%	$115.1M+9.1%	$105.5M	N/A
Accounts Receivable	$686.1M-7.7%	$743.0M-4.2%	$775.5M	N/A
Goodwill	$879.5M+3.2%	$852.1M+0.9%	$844.7M0.0%	$844.7M
Total Liabilities	$3.6B+5.0%	$3.4B-5.9%	$3.6B	N/A
Current Liabilities	$1.0B+10.7%	$945.4M-4.9%	$994.1M	N/A
Long-Term Debt	$1.1B-0.9%	$1.1B-7.1%	$1.2B	N/A
Total Equity	$1.3B+13.8%	$1.1B+68.6%	$670.9M-35.5%	$1.0B
Retained Earnings	$501.6M+37.1%	$365.8M+135.3%	$155.5M	N/A

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Total Assets	$5.3B+2.6%	$5.2B+2.5%	$5.0B+2.4%	$4.9B-0.9%	$5.0B+3.3%	$4.8B+4.2%	$4.6B	N/A
Current Assets	$2.1B+5.2%	$2.0B+4.3%	$1.9B+6.6%	$1.8B-3.9%	$1.8B+8.4%	$1.7B+12.6%	$1.5B	N/A
Cash & Equivalents	$709.6M+16.4%	$609.4M+12.7%	$540.6M+9.2%	$495.0M-11.1%	$556.8M-1.1%	$563.1M+68.3%	$334.5M-10.3%	$372.8M
Inventory	$118.6M-2.5%	$121.6M+2.7%	$118.4M-1.6%	$120.4M+4.6%	$115.1M+6.3%	$108.2M+3.1%	$105.0M	N/A
Accounts Receivable	$686.1M-5.9%	$729.4M-3.9%	$758.6M-2.3%	$776.5M+4.5%	$743.0M+5.3%	$705.7M-2.1%	$721.0M	N/A
Goodwill	$879.5M+0.2%	$877.5M0.0%	$877.7M+0.1%	$876.6M+2.9%	$852.1M0.0%	$852.0M0.0%	$852.0M	N/A
Total Liabilities	$3.6B+2.3%	$3.5B+4.2%	$3.4B+1.0%	$3.3B-2.5%	$3.4B+0.6%	$3.4B-1.0%	$3.4B	N/A
Current Liabilities	$1.0B+11.0%	$943.2M+7.1%	$880.9M+6.1%	$830.1M-12.2%	$945.4M+6.5%	$887.3M-2.3%	$908.6M	N/A
Long-Term Debt	$1.1B-1.0%	$1.1B-0.3%	$1.1B0.0%	$1.1B+0.4%	$1.1B+0.2%	$1.1B+0.2%	$1.1B	N/A
Total Equity	$1.3B+4.0%	$1.2B-1.3%	$1.3B+6.8%	$1.2B+3.9%	$1.1B+12.5%	$1.0B+35.9%	$739.9M-33.3%	$1.1B
Retained Earnings	$501.6M+9.8%	$456.7M-4.9%	$480.1M+17.9%	$407.2M+11.3%	$365.8M+45.4%	$251.6M+11.7%	$225.3M	N/A

ARDT Cash Flow Statement

Metric	FY25	FY24	FY23	FY22
Operating Cash Flow	$470.5M+49.4%	$315.0M+42.1%	$221.7M+678.0%	-$38.4M
Capital Expenditures	N/A	N/A	N/A	N/A
Free Cash Flow	N/A	N/A	N/A	N/A
Investing Cash Flow	-$214.2M+2.8%	-$220.5M-59.8%	-$138.0M-396.2%	$46.6M
Financing Cash Flow	-$103.5M-519.9%	$24.6M+124.1%	-$102.3M+62.2%	-$270.3M
Dividends Paid	N/A	$0	$0-100.0%	$174.8M
Share Buybacks	N/A	N/A	N/A	N/A

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Operating Cash Flow	$223.4M+44.7%	$154.4M+31.4%	$117.5M+574.0%	-$24.8M-120.7%	$119.6M+33.3%	$89.7M-25.5%	$120.4M+919.9%	-$14.7M
Capital Expenditures	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Investing Cash Flow	-$86.2M-47.1%	-$58.6M-26.8%	-$46.2M-100.0%	-$23.1M+78.1%	-$105.4M-136.9%	-$44.5M-14.5%	-$38.9M-22.9%	-$31.6M
Financing Cash Flow	-$37.0M-37.6%	-$26.9M-4.9%	-$25.7M-85.5%	-$13.8M+32.5%	-$20.5M-111.2%	$183.4M+253.1%	-$119.8M-548.1%	-$18.5M
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

ARDT Financial Ratios

Metric	FY25	FY24	FY23	FY22
Gross Margin	N/A	N/A	N/A	N/A
Operating Margin	N/A	N/A	N/A	N/A
Net Margin	2.1%-1.4pp	3.5%+2.5pp	1.0%-2.7pp	3.7%
Return on Equity	10.5%-8.0pp	18.6%+10.6pp	8.0%-10.1pp	18.2%
Return on Assets	2.6%-1.7pp	4.2%+3.1pp	1.1%	N/A
Current Ratio	1.97+0.0	1.94+0.3	1.63	N/A
Debt-to-Equity	0.84-0.1	0.96-0.8	1.74	N/A
FCF Margin	N/A	N/A	N/A	N/A

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Gross Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Margin	2.8%+4.3pp	-1.5%-5.9pp	4.4%+1.7pp	2.8%-4.3pp	7.1%+5.3pp	1.8%-1.1pp	2.9%+1.0pp	1.9%
Return on Equity	3.5%+5.4pp	-1.9%-7.7pp	5.8%+2.3pp	3.5%-6.6pp	10.1%+7.5pp	2.6%-3.2pp	5.8%+3.3pp	2.4%
Return on Assets	0.9%+1.3pp	-0.5%-1.9pp	1.5%+0.6pp	0.8%-1.5pp	2.3%+1.8pp	0.5%-0.4pp	0.9%	N/A
Current Ratio	1.97-0.1	2.08-0.1	2.130.0	2.12+0.2	1.94+0.0	1.91+0.3	1.65	N/A
Debt-to-Equity	0.84-0.0	0.880.0	0.87-0.1	0.93-0.0	0.96-0.1	1.08-0.4	1.46	N/A
FCF Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Similar Companies

P3 HEALTH PARTNERS INC PIII

$9.0M

Aveanna Healthcare Holdings, Inc. AVAH

$1.4B

Guardian Pharmacy Services, Inc. GRDN

$2.4B

Brookdale Sr Living Inc BKD

$3.3B

National Health NHC

$2.5B

Frequently Asked Questions

What is Ardent Health's annual revenue?

Ardent Health (ARDT) reported $6.3B in total revenue for fiscal year 2025. This represents a 6.0% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Ardent Health's revenue growing?

Ardent Health (ARDT) revenue grew by 6% year-over-year, from $6.0B to $6.3B in fiscal year 2025.

Is Ardent Health profitable?

Yes, Ardent Health (ARDT) reported a net income of $135.8M in fiscal year 2025, with a net profit margin of 2.1%.

How much debt does Ardent Health have?

As of fiscal year 2025, Ardent Health (ARDT) had $709.6M in cash and equivalents against $1.1B in long-term debt.

What is Ardent Health's net profit margin?

Ardent Health (ARDT) had a net profit margin of 2.1% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

What is Ardent Health's return on equity (ROE)?

Ardent Health (ARDT) has a return on equity of 10.5% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Ardent Health's operating cash flow?

Ardent Health (ARDT) generated $470.5M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Ardent Health's total assets?

Ardent Health (ARDT) had $5.3B in total assets as of fiscal year 2025, including both current and long-term assets.

How many shares does Ardent Health have outstanding?

Ardent Health (ARDT) had 143M shares outstanding as of fiscal year 2025.

What is Ardent Health's current ratio?

Ardent Health (ARDT) had a current ratio of 1.97 as of fiscal year 2025, which is generally considered healthy.

What is Ardent Health's debt-to-equity ratio?

Ardent Health (ARDT) had a debt-to-equity ratio of 0.84 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Ardent Health's return on assets (ROA)?

Ardent Health (ARDT) had a return on assets of 2.6% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Ardent Health's Piotroski F-Score?

Ardent Health (ARDT) has a Piotroski F-Score of 5 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Ardent Health's earnings high quality?

Ardent Health (ARDT) has an earnings quality ratio of 3.46x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

How financially healthy is Ardent Health?

Ardent Health (ARDT) scores 50 out of 100 on our Financial Profile, indicating moderate overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.